Department of Urology, Austin Hospital, Melbourne, Australia.
BJU Int. 2011 Oct;108(8 Pt 2):E184-9. doi: 10.1111/j.1464-410X.2011.10165.x. Epub 2011 Mar 25.
•To investigate the incidence of carcinoma of the prostate (CaP) in Sri Lanka and compare the rates with the migrant population in the UK.
•The Sri Lanka cancer registry data were used to determine the rates of CaP in Sri Lanka from 2001 to 2005. •The incidence of CaP in 8,426,000 men, aged ≥30 years, was analysed using 5-year age bands and age-standardized rates were calculated using European standard population data. •The relative risk was calculated by comparison with the South Asian migrant population in the UK using the Prostate Cancer in Ethnic Subgroups (PROCESS) study data, a population-based retrospective cohort study of 2140 men carried out over a 5-year period in four predefined areas of southern England. •Data from incidental findings of CaP in Sri Lanka on transurethral resection of the prostate (TURP) specimens were also analysed.
•In all, 1378 new cases of CaP were diagnosed during the 5-year period with a mean age of 69.2 years at diagnosis. •Compared with the previous 5 years, the incidence of CaP had doubled to 5.7 per 100,000, but was significantly lower than in the PROCESS study (relative risk 0.25). •Districts with a higher population density had higher adjusted rates of CaP in Sri Lanka (5.8-12.4 per 100,000). •For TURP specimens, 16.8-18.75% had incidental diagnoses of CaP in Sri Lanka, higher than other published studies.
•The Sri Lankan cancer registry data showed a low rate of CaP, similar to other South Asian countries, but the actual incidence of CaP in Sri Lanka is probably higher than reported, as seen in the densely populated districts and the high rate of incidental diagnosis of CaP in TURP specimens. •The incidence of CaP in migrant South Asians in the UK was much higher than in Sri Lanka. •Further studies are required to examine the environmental and genetic components which may be responsible for the low incidence of CaP in Sri Lanka.
利用斯里兰卡癌症登记处的数据,确定 2001 年至 2005 年期间斯里兰卡的 CaP 发病率。
对年龄在 30 岁及以上的 842.6 万男性进行了 5 年年龄组分析,并使用欧洲标准人口数据计算了年龄标准化发病率。
通过与英国南亚移民人群的比较,使用前列腺癌在少数民族群体中的研究(PROCESS)研究数据,对发病率进行了相对风险的计算。这是一项在英格兰南部四个指定地区进行的为期 5 年、涉及 2140 名男性的基于人群的回顾性队列研究。
还对经尿道前列腺切除术(TURP)标本偶然发现的 CaP 数据进行了分析。
在这 5 年期间,共诊断出 1378 例新的 CaP 病例,诊断时的平均年龄为 69.2 岁。
与前 5 年相比,CaP 的发病率增加了一倍,达到每 10 万人 5.7 例,但明显低于 PROCESS 研究(相对风险 0.25)。
斯里兰卡人口密度较高的地区,CaP 的调整发病率也较高(每 10 万人 5.8-12.4 例)。
在 TURP 标本中,斯里兰卡偶然诊断出 CaP 的比例为 16.8-18.75%,高于其他已发表的研究。
斯里兰卡癌症登记处的数据显示,CaP 的发病率较低,与其他南亚国家相似,但斯里兰卡的实际 CaP 发病率可能高于报告的发病率,这在人口密集的地区和 TURP 标本中偶然诊断出 CaP 的高发病率中可以看到。
英国南亚移民人群中 CaP 的发病率远高于斯里兰卡。
需要进一步研究环境和遗传因素,这些因素可能是导致斯里兰卡 CaP 发病率低的原因。